Serological Testing Market Report (2022 to 2030)

Pune, Oct. 17, 2022 (GLOBE NEWSWIRE) — The global Serological Testing market is expected to clock US$ 7.6 billion by 2030. The market is driven by increasing rates of HIV transmission, increasing COVID-19 cases, rising hepatitis B & C patients, and a threat from new viruses. Additionally, growing affordability for testing, precise diagnosis, and the introduction of novel diagnosis methodologies are contributing to the growth of the global serological testing market.

Excerpts from ‘Competitive Landscape’

The prominent players operating in the global serological testing market are:

• Abbott Laboratories Inc
• Quidel Corporation
• Beckman Coulter, Inc
• Becton Merck KGaA
• bioMérieux SA
• Grifols, S.A
• DiaSorin S.p.A
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd
• Mylab Discovery Solutions Pvt. Ltd
• Tulip Diagnostics Ltd. (PerkinElmer Inc.)
• Siemens Healthineers AG
• Sysmex Corporation
• Becton
• Dickinson & Co
• Thermo Fisher Scientific Inc

Download PDF Brochure of Serological Testing Market Size – COVID-19 Impact and Global Analysis with Strategic Developments at: https://growthplusreports.com/inquiry/request-sample/serological-testing-market/7872

Growth Drivers

HIV is a human immunodeficiency virus, usually attacking immunological cells that fight against antigens and infections. Acquired immunodeficiency syndrome (AIDS) is a late-stage HIV infection wherein the immunity system is severely damaged. The infected individuals are likely to develop diseases and acquire infections at a higher rate. From time to time, diagnosis is needed to monitor viral load in such patients. HIV diagnosis is made by rapid antigen test, western blot method, ELISA testing, and RTPCR. According to the Centers for Diseases Control and Prevention, in 2019, nearly 34,800 new HIV cases were registered in the United States. Approximately 80% of transmission of HIV occurs due to not receiving regular care or persons who do not know they have HIV. It is estimated that in 2019 around 1,189,700 people in the United States had…